Holen Sie sich die Stockscreener-App
4.575
24.55%
-1.575
Schlusskurs vom Vortag:
$6.15
Offen:
$5.115
24-Stunden-Volumen:
2.39M
Relative Volume:
0.43
Marktkapitalisierung:
$17.55M
Einnahmen:
$2.07M
Nettoeinkommen (Verlust:
$-3.53M
KGV:
-3.8893
EPS:
-1.1763
Netto-Cashflow:
$-3.31M
1W Leistung:
+221.11%
1M Leistung:
+229.08%
6M Leistung:
+94.14%
1J Leistung:
+85.60%
1-Tages-Spanne:
$4.30
$5.45
1-Wochen-Bereich:
$1.46
$8.48
52-Wochen-Spanne:
$1.0266
$8.48
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Firmenname
Cyclerion Therapeutics Inc
Sektor
Branche
Telefon
617-621-7722
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Compare CYCN vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
4.61 | 23.41M | 2.07M | -3.53M | -3.31M | -1.1763 |
VRTX
Vertex Pharmaceuticals Inc
|
435.20 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
759.39 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.94 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.34 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-20 | Eingeleitet | Truist | Buy |
| 2021-09-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Eingeleitet | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Aktie (CYCN) Neueste Nachrichten
CYCN stock is soaring 150% pre-market today — what is fueling the rally? - MSN
CYCN PE Ratio & Valuation, Is CYCN Overvalued - Intellectia AI
If You Invested $1,000 in Cyclerion Therapeutics Inc (CYCN) - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today - Sahm
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) - Sahm
Korsana Biosciences and Cyclerion Therapeutics Announce All-Stock Merger and $380 Million Financing - Global Legal Chronicle
Monteverde & Associates Investigates Cyclerion Therapeutics Merger - National Today
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
CYCN Plunges 17% After Merger Announcement: What’s Next for Cyclerion and Korsana? - Bitget
Cyclerion and Korsana Tie the Knot with a New Merger Strategy - StocksToTrade
Cyclerion Therapeutics Merger Sparks Investor Uncertainty - timothysykes.com
Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here? - Inkl
Korsana boosts Alzheimer’s work with reverse merger, $380M financing - BioWorld MedTech
Cyclerion Therapeutics and Korsana Biosciences Announce $380M Merger to Advance Alzheimer’s Treatment KRSA-028 - Minichart
CYCN Earnings History & Surprises | EPS & Revenue Results | CYCLERION THERAPEUTICS INC (NASDAQ:CYCN) - ChartMill
12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders - The Joplin Globe
Cyclerion Therapeutics, Inc. (CYCN) stock price, news, quote and history - Yahoo Finance UK
Cyclerion Therapeutics Merges with Korsana Biosciences in New Agreement - El-Balad.com
Korsana takes its brain shuttle tech public via reverse merger with Cyclerion - FirstWord Pharma
Shareholder Alert: Ademi LLP investigates whether Cyclerion Therapeutics Inc. is obtaining a Fair Price for Public Shareholders - PR Newswire
Korsana Biosciences and Cyclerion Therapeutics to Merge, Operate Under Korsana Name - Contract Pharma
Cyclerion Therapeutics to Merge with Korsana Biosciences - TipRanks
Cyclerion Therapeutics: $380 Million Financing To Merge With Korsana Biosciences And Advance Alzheimer’s Pipeline - Pulse 2.0
Cyclerion Therapeutics (NASDAQ: CYCN) to merge with Korsana, $380M PIPE backing - Stock Titan
Cyclerion to Merge With Korsana; $380 Million PIPE, CVRs and Lock-Ups Support Deal - TradingView
Korsana Biosciences to go public via Cyclerion (CYCN) reverse merger and $380M PIPE - Stock Titan
Korsana Taps Cyclerion For $380M Public Listing In Boston - Hoodline
Best Pharmaceutical Stocks To Follow NowApril 1st - MarketBeat
Promising Medical Stocks To ConsiderApril 1st - MarketBeat
Cyclerion Therapeutics stock soars 350% on Korsana merger, $380 million financing - MSN
Cyclerion provides public listing vehicle for Korsana in $380M deal - The Business Journals
Cyclerion Therapeutics, Inc. (CYCN) Stock: Skyrockets 324% on Blockbuster Korsana Merger Backed by Wall Street's Biggest Names - parameter.io
CYCN Stock Explodes 313% on April 1 After Cyclerion-Korsana Merger Deal for Alzheimer's Pipeline - International Business Times Australia
Crude Oil Down Over 1%; ISM Manufacturing PMI Rises In March - Benzinga
Why is Biotech Stock Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) Gaining? - Investorideas.com
Cyclerion Therapeutics, Korsana Biosciences enter merger agreement - TipRanks
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement - Business Wire
Cyclerion Therapeutics (CYCN) Stock Jumps 160% Following Korsana Biosciences Merger Announcement - MEXC Exchange
Trending Stocks Today | Cyclerion Therapeutics Shoots up 322.9% - Moomoo
Cyclerion Therapeutics and Korsana Biosciences To Merge - citybiz
Cyclerion Therapeutics Stock Soars 350% On Korsana Merger, $380 Million Financing - Benzinga
Cyclerion Therapeutics surges as it agrees to merge with Korsana Biosciences in a deal backed by a large private financing - Quiver Quantitative
Dow Jumps Over 200 Points; Nike Shares Tumble After Q3 Results - Benzinga
Cyclerion Therapeutics (CYCN) Stock Surges 160% on Korsana Merger Deal - MEXC
Financial Uncertainty Looms as CYCN Faces Market Changes - StocksToTrade
Alzheimer's-focused Korsana uses Cyclerion merger to go public - Fierce Biotech
$Cyclerion Therapeutics (CYCN.US)$ 🥳 - Moomoo
Cyclerion Therapeutics and Korsana Biosciences to merge - The Pharma Letter
CYCN Stock Is Soaring 274% Today — What Is Fueling The Rally? - Stocktwits
Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):